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studyquestion:Dothesocio-demographicand fertility-relatedcharacteristicsandmotivationsofoocytedonorsdiffer inEuropeancountries?
summaryanswer: The socio-demographic and fertility-related characteristics and motivations of oocyte donors differ considerably across
countries.
what is knownalready: Therehavebeennoother international studies comparing thecharacteristics of oocyte donors. Regarding their
motivations, most studies indicate mixed motives.
study design, size, duration: The proposed study was a transversal epidemiological study. Data were collected from 63 volun-
tarily participating assisted reproduction technology centres practising oocyte donation in 11 European countries (Belgium, Czech Republic,
Finland, France, Greece, Poland, Portugal, Russia, Spain,UK andUkraine). The surveywas conducted between September 2011 and June 2012
and ran for 1–6 calendar months depending on the number of cycles of oocyte donation performed at the centre. The sample size was com-
puted in order to allow an estimate of the percentage of a relatively rare characteristic (2%)with a precision (95% conﬁdence interval) of 1%.
The calculation gave 1118 donors.
participants/materials, setting, methods: In total, 1423 forms were obtained from oocyte donors. All consecutive
donors in these centres ﬁlled out an anonymous questionnaire when they started their hormonal stimulation, asking for their socio-demo-
graphic and fertility-related characteristics, their motivations and compensation. Population characteristics were described and compared
by country of donation. Motives for donation and mean amount of money were compared between countries and according to the donors
characteristics.
main results and the role of chance: The socio-demographic and fertility-related characteristics andmotivations of oocyte
donors varied enormously across European countries. The number of received forms corresponded with a participation rate of 61.9% of the
cycles performed by the participating centres.Mean agewas 27.4 years. About 49%of donorswere fully employed, 16% unemployed and 15%
student. Themotivation in the total group of donors was 47.8% pure altruism, 33.9% altruism and ﬁnancial, 10.8% pure ﬁnancial, 5.9% altruism
and own treatment and ﬁnally 2% own treatment only. About 15% of the donors were egg sharers (patient donors), mainly from the UK and
Poland.Womenwere donating for the ﬁrst time in 55.4% of cases, for the second time in 20.3% and for the third time in 12.8%. Themotivation
to donate was signiﬁcantly related to being of foreign origin (P, 0.01), age (P, 0.001), living in couple or not (P, 0.01), level of education
(P, 0.001) and number of donations (P, 0.001). The amount of compensation differed considerably between centres and/or countries.
The general donor proﬁle in this study was a well-educated, 27-year-old woman living with her partner and child who mainly donated to
help others.
limitations, reasons forcaution: The selectionof clinics in some countries and the limited participation ratemayhave led to a
bias in donor characteristics. A possible effect of social desirability in the answers by the donors should be taken into account.
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wider implications of the findings: The diversity of the donor population reﬂects the differences in European legislation (for
example, on anonymity and payment) and economic circumstances. The differences in systems of reimbursement/payment demonstrate the
need to have a thorough discussion on the speciﬁc meaning of these terms.
study funding/competing interest(s): The study was funded by the European Society for Human Reproduction and Em-
bryology. The authors declare no conﬂicting interests.
Key words: altruism / compensation / oocyte donors / ethics / motivation
Introduction
Oocyte donation is on the rise in many countries all over the world.
According to data collected for the European IVF Monitoring (EIM) pro-
gramme, 11 475 oocyte donation cycles were performed in 2005,
12 685 in 2006, 15 731 in 2007, 13 609 in 2008 and 22 323 in 2009
(Nyboe Andersen et al., 2009; de Mouzon et al., 2010, 2012; Ferraretti
et al., 2012, 2013). There have been concerns about this procedure
fromtheearlystart.Oocytedonation is still prohibited inanumberofEuro-
pean member states such as Germany, Austria and Italy. The main con-
cerns regard the safety of the donors, the exploitation of poor women
and the commodiﬁcation of the human body (Pfeffer, 2011; Danish
Council of Ethics, 2013). The relatively high amounts of money paid to
oocyte donors in the USA undoubtedly have contributed to these con-
cerns. Add to that a number of clear violations of the rules of good clinical
practice in some clinics, widely reported in the news media, and one has
the perfect recipe for a heateddebate. In 2005, for instance, serious short-
comings were demonstrated in Romanian clinics, where oocyte donors
had not given informed consent, had received inadequate information
regarding the possible health risks of the procedure and had not received
follow-up care when complications resulted (Magureanu, 2005). Policy
makers both at national and European level have taken a position. Ques-
tions were asked in the European Parliament regarding the safety of the
procedure and about the risk of exploitation of women. A ﬁnal point
thatpushedoocytedonationtothe forefront is the internationaldimension
of recruitment and themovements of candidate recipients across national
borders. The search for donor oocytes is one of the main reasons for
patients seeking cross-border reproductive care, either because the na-
tional legislation forbids the use of donor oocytes or because the waiting
lists at home are too long (Shenﬁeld et al., 2010). Other elements of the
procedure, such as anonymity/identiﬁability and payment/reimburse-
ment, have also contributed to large differences across Europe.
The European Society for Human Reproduction and Embryology
(ESHRE), as the main assisted reproduction technology (ART) profes-
sional society in Europe, has taken up these concerns. In 2011 a good
practice guide for cross-border patients was published which covered
partly the worries about oocyte donation (Shenﬁeld et al., 2011). Data
collection is the ﬁrst step towards an informed debate. Therefore, the
ESHRE Task Force on Cross-Border Reproductive Care together with
the EIM Consortium decided to perform an international study to
collect empirical data in order to answer some of the main questions
about oocyte donation. This information will be useful to all stake-
holders, from patients to clinical teams to policy makers.
Objectives
Themainobjectivesof the studywere (i) toobtain reliable informationon
oocyte donors in Europe (their origin and residence, their characteristics
(social, demographic, reproductive history), their reasons for donating
and the reimbursement they receive for the donation), (ii) to compare
the differences in socio-demographic and fertility-related characteristics
and motivations across countries and (iii) to ﬁnd out which donor
characteristics relate with the motivations.
Study characteristics
The proposed study is a transversal epidemiological study on donors
recruited during a relatively short period of time in selected centres
from European countries in which oocyte donation is performed,
based on an anonymous questionnaire for donors.
Materials andMethods
The selection of the countries started by taking all European countries per-
forming .100 donation cycles per year, as reported or estimated in the
EIM report 2010 (representing cycles performed in 2007). This resulted in
a list with 13 countries: Belgium, Cyprus, Czech Republic, Finland, France,
Greece, Poland, Portugal, Russia, Spain, Sweden, UK and Ukraine. The
next step was to look for a coordinator who was willing to participate. This
ﬁnally left us with 11 remaining countries, minus Cyprus and Sweden. In
each country, the national coordinator (listed in the Acknowledgements)
contacted the centres performing at least 50 cycles of oocyte donation per
year. The centres that agreed to participate received the summarized proto-
col, the forms and instructions. They were asked to enrol all consecutive
oocyte donors starting hormonal stimulation during a speciﬁc number of
months. This included ‘egg sharers’, that is IVF or ICSI patients who share
some of their oocytes with another woman. The donors were recruited
during the stimulation cycle, according to the possibilities in the clinic. The
period during which the centres enrolled donors depended on the number
of cycles the centre performed per year; the lower the number of cycles,
the longer the study period.
We designed two questionnaires. The donor’s form consisted of a
two-pagequestionnaire (see Supplementary data) containing themain socio-
demographic characteristics (age, marital status, sexual orientation, educa-
tion, reproductive history), themain reasons fordonating (altruism, obtaining
treatment, ﬁnancial beneﬁt), the information and counselling received and
the expected compensation for the donation. The country coordinators
also translated the instructions to participating collaborators and the ques-
tionnaires in all languages of the different countries. Whenever appropriate,
patients could tick more than one answer. Almost all questions were closed
questions.
In addition, each clinic was asked to complete a short questionnaire,
recording the total number of donations performed during the study and
the arrangements regarding compensation. The survey was conducted
betweenSeptember 2011and June2012.Thenumberof received formscor-
responded with a participation rate of 61.9% of the cycles performed by the
participating centres but it was not possible to know how many were not
asked to participate or how many refused to participate.
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The study was approved by the appropriate ethics committees, ac-
cording to the rules of each collaborating country. Donor anonymity was
guaranteed.
In order to analyse and compare the compensation given to donors in dif-
ferent countries, we used the notion of purchasing power parity (PPP). PPPs
are the rates of currency conversion that equalize the purchasing power of
different currencies by eliminating the differences in price levels between
countries. The mean PPP of the European Union is 1.0. In their simplest
form, PPPs are price relatives that show the ratio of the prices in national cur-
rencies of the same goods or service in different countries. This takes into
account both the cost of a similar item in different countries, and the different
earning powers in these countries (Taylor and Taylor, 2004).
Statistical aspects
Donor sample size
The sample size was computed for a descriptive study to allow to estimate a
percentage of a relatively rare characteristic (2%) with a precision (95%
conﬁdence interval) of 1%. The calculation gave 1118 donors. Such a
number was also large enough to allow many comparisons with a power of
80% to be made.
Data were entered at BIG (Bioethics Institute Ghent) and ESHRE Central
Ofﬁce and analysed at INSERM (Institut National de la Sante´ et de la Recher-
cheMe´dicale) with the SAS software system, version 9.1. (SAS Institute, Inc.,
Cary, NC, USA).
Statistical analysis
Standard descriptive statistics were performed on the population. The col-
lected data were described with percentages or means associated with
their SD.
Resultswere given for thewhole set of patients andbycountryof treatment.
Donors’ answers were also compared by country of treatment. Chi-
square testswere used to compare the percentages of population character-
istics across countries, and the percentages of motives according to the total
population characteristics. Variance analysis was used to compare mean age
across countries or mean amount of money across total population
characteristics.
A P-value of≤0.05was considered statistically signiﬁcant. In all the follow-
ing sections, only signiﬁcant differences were reported. Analyses were per-
formed with the SAS software.
Results
Socio-demographic characteristics and
fertility history
General description of the donor population
In total, 1423 forms were received from 63 clinics in 11 countries
(Table I). Spain provided by far the largest percentage of forms
(31.6%), followed by the Czech Republic (12.2%) and Finland (close to
10%). The other countries contributed between 3 and 8%.
Residence of the donor
Throughout the report, the reference todonors of a certain country indi-
cates donors who donated in that country. It gives no direct information
on the country of residence or country of origin of the donor. In most
countries, almost all donors also had their residence in the country.
The only exception was Belgium where only 47 of the 65 donors lived
in the country. The largest group of foreign donors in Belgium came
from France (15/18) and they were donating to a family member or
friend (12/15).
Country of origin of the donor
When the country of origin (i.e. country of birth) was considered, four
countries had a considerable percentage of immigrant donors: Greece
(57.9%), Belgium (31.3%), UK (15.7%) and Spain (14.1%). Belgium dif-
fered from the other countries in the fact that most donors born in
another country did not reside in Belgium either. Greece had a
mixture of donors from ex-Soviet Union member states (Georgia n ¼
10, Russia n ¼ 6, Ukraine n ¼ 2) and eastern European countries
(Romania n ¼ 8, Bulgaria n ¼ 5, Poland n ¼ 4). In all, two nationalities
.............................................................................................................................................................................................
Table I Distribution of forms per country for a study of the socio-demographic and fertility-related characteristics and
motivations of oocyte donors in eleven European countries.
Country Centres Forms Not resident in the country Not born in the country Living in couplea Age (years)
N N % % % M+ SD
Belgium 4 65 27.7 31.3 78.1 30.2+3.9
Czech Republic 4 174 0.0 0.0 74.4 26.9+4.2
Finland 10 141 1.4 3.6 58.9 28.4+4.9
France 7 60 0.0 6.8 81.7 31.0+4.5
Greece 5 76 1.3 57.9 49.3 27.9+4.0
Poland 6 107 0.9 0.9 86.5 29.5+3.6
Portugal 3 100 0.0 25.5 33.3 26.6+4.3
Russia 2 49 0.0 0.0 68.7 27.1+3.4
Spain 15 449 0.2 14.1 41.6 25.6+3.9
UK 6 116 0.0 15.7 92.2 30.1+3.8
Ukraine 1 86 0.0 0.0 77.9 26.6+2.9
Total 63 1423 1.6 12.9 61.1 27.4+4.0
P , 0.001 ,0.001 ,0.001 ,0.001
aMarried or living together.
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in terms of country of origin stood out: Brazil (n ¼ 21) and Romania
(n ¼ 24). The donors born in Brazil were mostly found in Portugal
while the Romanian women donated in Spain. In the total population,
donors of 54 different countries of origin were present.
Mean age of the donor
Themean ageof the donors ranged from25.6 years in Spain to31.0 years
in France. The mean age overall was 27.4 (+4 years) with a range from
18 to 40 years. There were 70 donors (4.9%) below the age of 21 years
and 70 donors (4.9%) were 35 years or older. (Table I).
Civil status
Civil statusdiffered greatlydependingon thecountry. In general, 61.1%of
donors were living in couple, eithermarried or cohabiting. Both Portugal
and Spain had .50% single women, followed by Finland and Greece
around 30% (Table I). The highest percentages of divorced women
came from Greece (17.1%) and Russia (16.3%).
Living circumstances
Of all donors, 19.3% were living with their parents. In three countries
(Portugal, Spain and Ukraine), this percentage was higher than 30%.
Professional activity
The highest number of students was found in Spain (24.9%), Finland
(22%) and the Czech Republic (15.3%) (Table II). The highest number
of unemployed donors was found in Spain (23.8%), Ukraine (22.4%)
and Greece (18.8%). Full employment was on average 48.7%. Full em-
ployment was the lowest in Spain (28%) and Greece (29%) and the
highest in Belgium (75.4%), the UK (73.6%) and Poland (69.5%).
Educational level
One-third of all donors had a university degree and 40.5% had a second-
ary level education (Table II). The differences amongst countries were
again considerable. More than half of the donors had a university
degree in Belgium, France, Poland and the Ukraine. The lowest per-
centage of university educated donors could be found in the Czech
Republic with 4.7%. Regarding technical/professional education,
Finland (43.6%) and Russia (45.8%) scored highest, followed by the
Ukraine (32.6%) and then France, Greece, Poland and Spain (all slightly
more than 20%).
Reproductive history
Of the donors, 52.3% had at least one child of their own (Table III).
Among these, 28.7% had one child, 18.4% had two and 5.2% had
three or more children. In Russia and the Ukraine almost all women
had children. In France,.90%of donors had had a child. The lowest pro-
portions were in Poland, Portugal, Spain and the UK with 35%.
Among thedonors, 15.7%hadexperiencedat leastonemiscarriage. In
total, 17.7% has had an elective abortion. The percentage of elective
abortions increased with age until 25–29 years with 24.0% and then
decreased, dropping to 11.6% after 35 years (P, 0.01). This evolution
was the same inmost countries apart fromFrance andGreecewhere the
highest percentage of abortions was observed among the youngest
donors. The abortion rate was very high for all age categories in Russia
(53.1%).
Altogether, about 11.6% of the donors had themselves suffered from
infertility but Poland and the UK stood out with 55%. Furthermore,
4.7% had achieved their own pregnancy through infertility treatment in
general while this was 26.7% in the UK.
Sexual orientation
In total 88%of donorswereheterosexual, 3.8%homosexual, 2.4%bisex-
ual and5.8%gavenoanswer to thequestion.Therewereagain fairly large
differencesbetween thecountries (Table III). TheUKsample for instance
contained 22.4% lesbian women while the Ukraine had none. In the
Czech Republic .20% of the respondents refused to answer or gave
no answer to this question.
................................................................................ .............................................................................
.............................................................................................................................................................................................
Table II Oocyte donor characteristics across countries: professional activity and educational level.
Professional activity Educational level
Full-time Part-time Unemployed Student Primary Secondary Technical University
% % % % % % % %
Belgium 75.4 10.8 12.3 1.5 3.1 35.4 9.2 52.3
Czech Republic 56.7 12.0 16.0 15.3 11.0 80.2 4.1 4.7
Finland 62.4 13.5 2.1 22.0 5.0 15.7 43.6 35.7
France 61.7 28.3 10.0 0.0 1.7 13.3 23.3 61.7
Greece 29.0 47.8 18.8 4.4 11.8 39.5 22.4 26.3
Poland 69.5 15.2 10.5 4.8 4.7 19.6 20.6 55.1
Portugal 50.5 9.1 9.1 31.3 0.0 53.0 8.0 39.0
Russia 59.6 23.4 14.9 2.1 0.0 20.8 45.8 33.3
Spain 28.0 23.3 23.8 24.9 8.3 46.7 22.5 22.5
UK 73.6 16.0 8.5 1.9 0.9 40.0 11.3 47.8
Ukraine 42.3 31.8 22.4 3.5 0.0 16.3 32.6 51.2
All 48.7 20.2 15.7 15.4 5.7 40.5 21.1 32.7
P ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
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Egg sharing
There were 222 egg sharers (15.6% of the total) (sometimes also called
patient donors) among the respondents.More than half of them (55.4%)
either did not answer the question on reimbursement or said that they
would not receive any refund. Most egg sharers came from Poland and
the UK (31.5 and 41.0%, respectively). The proportion of egg sharers
among the total number of oocyte donors in the UK was 78.4%,
65.4% in Poland, 19.7% in Greece and 11.6% in Ukraine (Table III). In
the other countries, egg sharing did not represent .10% of the cycles.
It seems that egg sharing was an unequally distributed protocol; some
clinics clearly specialized in this type of recruitment while others did not.
Number of donation cycles
Womenweredonating for the ﬁrst time in 55.4%of cases, for the second
time in 20.3%, for the third time in 12.8% and more often in 11.5%
(Table IV). When we calculated the mean number of cycles by
country, the Ukraine was leading with 1.85 cycles per donor, followed
by the Czech Republic (1.75), Russia (1.30) and Spain (1.13). Countries
with a high percentage of women who were donating for a second or
higher number of times were the Czech Republic (69.1%), Spain
(61.1%) and the Ukraine (60%). The percentage of ﬁrst-time donors
was very high in Belgium (92.2%), France (91.7%), Poland (82.7%) and
theUK (82.6%).Whenone looked at donorswith four ormoreprevious
.............................................................................................................................................................................................
Table III Reproductive history and sexual orientation of oocyte donors.
≥1
child
Miscarriage Elective
abortion
Infertility Pregnancy after
treatment
Homosexual Bisexual Egg
sharers
% % % % % % % %
Belgium 73.9 21.5 9.2 10.9 9.2 6.1 1.5 4.6
Czech
Republic
67.1 6.9 13.8 3.0 0.6 0.0 1.8 0.6
Finland 53.2 16.3 14.9 6.8 0.0 1.4 8.6 1.4
France 96.6 23.3 18.3 8.3 10.0 3.3 0.0 1.7
Greece 52.6 7.9 9.2 18.7 10.5 0.0 0.0 19.7
Poland 35.5 16.8 4.7 54.7 12.2 2.0 0.0 65.4
Portugal 36.0 6.0 15.0 0.0 0.0 1.0 2.2 5.0
Russia 100 14.3 53.1 0.0 2.0 2.2 2.2 8.2
Spain 34.8 18.5 23.2 0.2 0.2 3.4 2.7 4.5
UK 37.9 31.0 11.2 54.9 26.7 22.8 1.8 78.4
Ukraine 98.8 5.8 23.3 0.0 0.0 0.0 1.2 11.6
All 52.3 15.7 17.7 11.6 4.7 3.8 2.4 20.3
P ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.01 ,0.001
................................................. ....................................................................
.............................................................................................................................................................................................
Table IV Number of previous oocyte donation cycles, relationship with the recipient and the future child.
Number of previous cycles Relationship with the recipient Anonymity towards child
0 1 2 3 ≥4 Friend Family Exchange Unknown
% % % % % % % % % %
Belgium 92.2 4.7 0.0 3.1 0.0 6.1 26.2 41.5 26.2 76.6
Czech Republic 30.9 30.9 9.7 13.3 15.2 0.0 0.6 2.4 97.0 95.8
Finland 50.0 27.9 10.7 6.4 5.0 2.8 5.0 5.0 87.2 5.0
France 91.7 6.7 0.0 1.6 0.0 11.7 8.3 56.7 23.3 93.0
Greece 64.9 20.3 12.2 1.3 1.3 0.0 0.0 0.0 100 100.0
Poland 82.7 10.6 6.7 0.0 0.0 7.7 7.7 0.0 84.6 100.0
Portugal 77.8 14.1 8.1 0.0 0.0 0.0 0.0 0.0 100 87.8
Russia 51.2 14.0 11.6 13.9 9.3 0.0 4.3 6.4 89.3 100.0
Spain 38.9 28.6 20.5 6.6 5.4 0.0 0.0 0.0 100 100.0
UK 82.6 7.8 6.1 0.9 2.6 4.4 4.4 4.4 86.9 15.6
Ukraine 40.0 3.7 25.0 13.8 17.5 0.0 2.3 3.5 94.2 95.3
All 55.4 20.3 12.8 5.9 5.6 2.0 3.3 5.9 88.8 79.0
P ,0.001 ,0.001 ,0.001
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cycles, again the Czech Republic with 15.2% and the Ukrainewith 17.5%
scored signiﬁcantly higher than the other countries (P, 0.001).
Relationship between donor and recipient
Among the total group of donors, 88.8% gave to an unknown woman
(Table IV). In addition, 5.9% gave to an unknown woman in exchange
for a friend or family member to receive oocytes. In Greece, Portugal
and Spain, all donors gave to a person unknown to them. In the following
countries 90% of the donors donated to an unknown person: Czech
Republic, Finland, Poland, Russia and Ukraine. A distinction has to be
made between donating to a person (i.e. the recipient uses the
oocytes of the donor for herself) and donating for a person (i.e. the re-
cipient receives oocytes from someone else in exchange for the
oocytes donated by the donor she brought with her). The latter
system has also been called personalized anonymity or cross-donation
(Raoul-Duval et al., 1992). In Belgium (73.8%) and France (76.7%), the
majority gave for and/or to a family member or friend. In Belgium,
32.3% gave to a family member or friend and 41.5% entered in a cross-
donation for a family member or friend. Out of the 60 donors in
France, 10 indicated that they donated to a friend or family member
for their own use.Only 23% gave to an unknown recipient; the remaining
donors entered into a cross-donation system.
Relationship between donor and donor offspring
In the total sample of donors, 79%will be anonymous for the child result-
ing from their donation. In the Czech Republic, France, Greece, Poland,
Russia, Spain andUkraine.90%of the donorswill be anonymous to the
child (Table IV). Although donors were only offered two options (an-
onymous or identiﬁable), there was a certain percentage of ‘no
answer’. In some of the countries above, a small percentage of the
donors indicated identiﬁability: in the Czech Republic 4%, France 6.7%,
Portugal 6% and the Ukraine 4.7%. In the other countries of the list
above, therewas no answer. In theUK (84%) and Finland (94%), thema-
jority of the donors indicated identiﬁability to the donor offspring in the
future. Belgium was the only country with a middle position with 21.5%
identiﬁable and 76.6% anonymous donors. The connection with the le-
gislation on donor anonymity will be discussed below.
Motives for donation
Donors could indicate more than one reason for donating and many of
them did. For the analysis of the results, the choices made by the
donors were grouped in ﬁve categories: pure altruism (helping infertile
people, a family member or a friend or combinations thereof), altruism
and ﬁnancial (in combination), pure ﬁnancial, altruism and obtaining
own treatment (in combination), and pure own treatment. For the
total group of donors, the following results were obtained: 47.8% pure
altruism, 33.9%altruismandﬁnancial, 10.8%pureﬁnancial, 5.4%altruism
and own treatment and ﬁnally 2% own treatment only (Table V). The
trends in the distribution over the countries can be summarized as
follows: high levels of pure altruism could be found in Belgium (86.2%),
Finland (88.7%) and France (100%). High proportions of donors indicat-
ing a pure ﬁnancial reason were present in Greece (39.5%), Russia
(52.3%) and the Ukraine (28.3%). The motivation in the two countries
with a high percentages of egg sharers (Poland and UK) were very differ-
ent: 23.2% indicated altruism and own treatment and 3.2% pure own
treatment in Polandwhile in theUK, thiswas, respectively, 47.3 and 20%.
Reimbursement
The data regarding reimbursement turned out to be highly complicated.
Apparently the precise meaning or purpose of the amount that donors
received was not always clearly indicated to them. It was ﬁnally
decided to use the data by the donors only if the centre did not
provide the relevant information in their centre questionnaire.
The situation in most countries differed considerably. A number of
countries applied a consistent policy across all centres. In France, only
reimbursement of proven expenseswas provided. In Portugal the specif-
ic sum of 627Ewas used. In the UK, a ﬁxed amount of 870E (750£) was
given as a compensation per cycle of donation to cover any ﬁnancial
losses incurred in connection with the donation. In Spain, the ﬁxed
amount was generally 900E (with some variability). In Finland, the
amount was ﬁxed at 250E; however a number of donors mentioned
amounts of up to 600E. The Russian centres gave no information on
compensation but the majority of the donors mentioned a sum of
600E (25.000 Roubles). The Ukraine gave a ﬁxed amount between
400E (4200 UAH) and 650E (6800 UAH). Again, however, some
donors mentioned amounts of up to 960E. The largest difference
between centres was found in Belgium where one centre offered
500E as a ﬁxed amount while another offered 2000E.
We also looked at the purchasing power instead of the ﬁxed amount
because this recalculation allowed us to take into account the welfare
level of the countries. The lowest PPP applied in Belgium (0.838) and
the highest in Ukraine (4.388). This means that the amount the donors
received should be multiplied by this rate in order to determine how
much the money is really worth in their country.
Counselling
The overwhelming majority (95%) of the donors declared having
received counselling about the medical risks of the procedure. The
only exception was Poland where only 78.6% answered this question
positively (Table V). The results were considerably worse for psycho-
logical implication counselling. The answer was negative for 36.8% of
the donors in Greece, 36.4% in Poland and 18.6% in Ukraine. Most
donors (98.2%) also received counselling in their mother tongue.
Relationships between donor characteristics
and motives for donation
There is a signiﬁcant relationship between being born in another country
and the motivation to donate (P, 0.01). Donors of foreign origin were
less likely to bemotivated by pure altruism than the donors of local origin
(41.7 versus 49.5%) and they were more likely to be purely ﬁnancially
motivated (19.4 versus 9.1%) (Table VI).
There is also a signiﬁcant relationship between the age of the donor
and the motives to donate (P, 0.001). Among donors younger than
25 years, 45.7% indicated pure altruism compared with 78.6% of those
above 35 years. Also 11.9% of those below 25 years were purely ﬁnan-
cially motivated compared with 1.4% of those older than 35 years.
(Table VI).
There is a statistically signiﬁcant relationship (P, 0.001) between
professional activity and motives for donation. Of the persons working
full time, 55% donated for purely altruistic reasons compared with
34.8% of the unemployed. Part-time working people and students
were situated in between these, with 44%. Still only 10.8%, a relatively
small proportion of donors in all groups donated for purely ﬁnancial
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Table V Motives for oocyte donation and counselling.
Motives for donation Counselling
Altruism Own
treatment
Financial Altruism1 own
treatment
Altruism 1 ﬁnancial Medical
risks
Psychological
implications
Information in mother
tongue
% % % % % % % %
Belgium 86.2 0.0 1.5 0.0 12.3 90.6 95.3 95.4
Czech
Republic
48.8 0.0 5.3 0.0 45.9 94.1 69.2 100
Finland 88.7 0.0 0.7 0.7 9.9 93.6 93.6 97.9
France 100 0.0 0.0 0.0 0.0 91.7 86.4 100
Greece 28.9 4.0 39.5 0.0 27.6 97.4 56.6 98.7
Poland 58.9 3.2 0.0 23.2 14.7 78.6 45.8 95.8
Portugal 76.3 0.0 4.1 0.0 19.6 98.9 95.8 98.9
Russia 18.2 0.0 52.3 0.0 29.5 100 88.4 100
Spain 30.4 0.0 19.1 0.0 56.5 96.2 92.2 99.3
UK 30.0 20.0 0.0 47.3 2.7 97.4 86.6 91.2
Ukraine 12.9 0.0 28.3 0.0 58.8 98.8 81.2 100
All 47.8 2.0 10.8 5.4 33.9 94.6 83.4 98.2
P ,0.001 ,0.001 ,0.001 ,0.001
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reasons (7.4% full time, 16.9% part time, 12.9% unemployed and 11.1%
students).
The level of education had an impact on the motives to donate. The
higher the level of education, the more altruistic the donor (P,
0.001) (Table VI).
The percentage of purely altruistically motivated donors was 54.3%
for those who donate for the ﬁrst time compared with 38.3% for
donors donating three or more times. The ‘pure ﬁnancial’ motive
(9.3% for the ﬁrst donation and 14.8% for third and higher) and especially
the ‘altruism and ﬁnancial’ motive (25.4 and 46.9%, respectively)
increasedwith thenumberof donations.The relationshipwas statistically
signiﬁcant (P, 0.001). (Table VII).
Weseparated thedonors according to theirmotivation and thencom-
bined thiswith the amount they indicated as compensation. This amount
was then recalculated with the PPP for the country in which they
donated. Donors who said to be purely ﬁnancially motivated received
a mean ﬁx sum of 867E (purchasing power 1357E), those motivated
by a mixture of altruistic and ﬁnancial motives 912E (purchasing
power 1188E) and the purely altruistic donors 706E (purchasing
power 821E). This relation is statistically signiﬁcant (P, 0.001).
(Table VII).
About 40%of the egg sharers participated in this procedure for purely
altruistic reasons.Aboutone in threehadmixed (altruismplusowntreat-
ment) motives. Only 11.6% indicated that they shared their oocytes
exclusively to be able to have their own treatment.
Centre data and donor proﬁle
In order to understand the distribution of characteristics among the
different countries, it is necessary to understand the legal situation in
the countries. This information is provided in Supplementary data.
Belgium
Donors’minimumagewasmostly 18 years but one centreused21 years.
Themaximumagewas34yearsand37years.Onecentredemanded that
the donor should already be a mother while none asked for marriage or
co-habitation. Some centres gave a ﬁxed amount plus proven expenses
while others only gave a ﬁxed amount. This amount ranged from 500 to
2000E. In return for egg sharing, some centres offered nothing while
others provided a full free IVF cycle.
Donor proﬁle: a cohabiting or married mother of 30 years, highly
educated with a full-time job and altruistically motivated. She donated
for the ﬁrst time and mostly to and/or for family and friends.
Czech Republic
Minimum agewas 18, 19 or 20 years andmaximum agewas 33, 34 or 35
years.Neithermotherhood normarriage or co-habitationwas required.
All centres only compensated for proven expenses. As a consequence,
most donors did not answer the question about compensation but
those who did mentioned an amount of 560E (15.000CZK). Nothing
was offered for egg sharing.
Donor proﬁle: a young mother with secondary education who
donated several times to an unknown recipient.
Finland
The minimum age ranged from 20 (most clinics) to 23 or 24 years while
themaximum agewas between 35 and 38 years. No clinic requested the
donor to be a mother, married or cohabiting before donation. Other
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criteria included (listed so not necessarily applicable in all centres): psy-
chologically, physically and genetically healthy (no genetic diseases). All
clinics reimbursed proven expenses and added a ﬁxed amount of 250E.
Donor proﬁle: a highly educatedwomanwhodonated to an unknown
recipient for purely altruistic reasons.
France
Minimum age is 18 years andmaximum age 37 or 38 years. Motherhood
is always requested but marriage or co-habitation was not. Only proven
expenses were reimbursed. Nothing was offered in return for egg
sharing.
Donor proﬁle: a cohabiting or married woman with child, older than
30 years and highly educated. She donated for purely altruistic reasons.
Greece
Minimum age ranged from 20 to 25 years and maximum age from 30 to
37 years. Only one centre required the donor to be a mother. Marriage
or co-habitation was not a condition. Additional medical/health criteria
were imposed. One clinic indicated that it only reimbursed proven
expenses, one gave a ﬁxed amount of 1400E and two others gave a
ﬁxedamount (between900and1000E) plus provenexpenses.Nocom-
pensation was offered for egg sharing.
Donor proﬁle: an average aged woman (27 years) who in many cases
was of foreign origin and was unlikely to work full time. She was single or
divorced and likely to be (purely) ﬁnancially motivated.
Poland
Minimum age ranged from 18 to 23 years and maximum age from 34 to
35 years. Only one centre required that the donor be a mother prior to
donation. Two centres required that the donor be married or
co-habiting. Additional criteria were a normal karyotype, no genetic dis-
orders and BMI within the normal range. Two out of six centres only
reimbursed proven expenses while others gave a ﬁxed amount ranging
from 935 to 1400E (4000–6000PLN). Regarding egg sharing, ﬁve out
of six centres funded a partial cycle in return.
Donor proﬁle: a slightly above average age woman (29.5 years) who
was likely to share her oocytes, was highly educated without children
and cohabiting or married.
Portugal
Minimum age was 18 years, maximum age 35 years. Motherhood and
marriage or co-habitation were not required but other conditions
applied: the donor could not be an adopted child herself, no tattoos or
piercings in the last year, normal BMI, height,185 cm, no strongly pro-
nounced physical traits. All centres gave a ﬁxed amount ranging from625
to 650E. No refund was given for egg sharing.
Donor proﬁle: a young woman who is single or divorced and has no
child. She is highly educated and donates to an unknown recipient for
purely altruistic reasons.
Russia
Minimum age was 20 years, maximum age 34 or 35 years. Both centres
required the donor to be already a mother and married or co-habiting.
They gave a ﬁxed amount plus expenses but did not mention the ﬁxed
amount. One centre gave a full IVF cycle in return for egg sharing.
Donor proﬁle: younger than average woman with child who had an
elective abortion and was highly educated. She donated in several
cycles and was likely to be purely ﬁnancially motivated.
Spain
Minimum age was mostly 18 years with two centres using 20 years.
Maximum age ranged from 30 to 35 years. The Spanish centres either
gave a ﬁxed amount only or a ﬁxed amount plus expenses. The ﬁxed
amount ranged from 700 to 1300E (PPP 727–1350). Nothing was
offered in return for egg sharing.
Donorproﬁle: youngwomanwho is unlikely towork full time, single or
divorced and without child, donates more than once. She donated for a
combination of altruistic and ﬁnancial reasons.
Ukraine
The number of centres participating is unknown as the questionnaires
were brought in as one package. As a consequence, it was impossible
to know whether there was variation in the rules applied by the
centres. On the basis of the differences in answers from the donors,
we concluded that several centres have participated. On the basis of
the data we received, both motherhood and marriage or co-habitation
were requested. Additional criteria included normal anti-Mullerian
hormone (AMH) and normal karyotype. The centres gave a ﬁxed
.................................................................................................
.............................................................................................................................................................................................
Table VII Motives for oocyte donation (%) in relation with number of previous cycles and the ﬁxed amount expected by
patients, in Euros and in PPP (purchasing power parity) euros.
Number of previous donations Euros PPP
0 1 2 3 ≥4 M+ SD M+ SD
% % % % % N N
Altruism 54.3 43.3 36.2 38.3 47.4 706+380 821+542
Own treatment 3.1 1.1 1.1 0.0 0.0 — —
Financial 9.3 8.7 16.1 14.8 7.9 867+253 1357+706
Altruism + own treatment 7.8 2.9 3.5 0.0 2.6 564+342 621+348
Altruism + ﬁnancial 25.4 44.0 43.1 46.9 42.1 912+305 1188+594
Total 100 (740) 100 (275) 100 (174) 100 (81) 100 (76) 820+330 1065+593
P ,0.001 ,0.001 ,0.001
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amount of 400–640E (4200or 6800UAH) (PPP 1754–2807). In return
for egg sharing, a partial IVF cycle was offered.
Donor proﬁle: young, highly educatedmotherwho donated in several
cycles for a combination of altruistic and ﬁnancial reasons.
UK
Minimum age used by the centres ranged from 18 to 25 years. Maximum
age was 35 years. Neither motherhood nor marriage or co-habitation
was requested. Additional conditions included BMI .21 kg/m2, no
family history of hereditary diseases, non-smokers, good AMH and
FSH. Fiveout of six centres indicated that theyonly paid provenexpenses
but at the same time some indicated that they also provided a ﬁxed
amount of 750£ (870E). Regarding egg sharing, all possibilities were
applied: some offered a full cycle, some a partial cycle and some
nothing at all.
Donor proﬁle: a woman of 30 years of age who was highly educated
and was most likely sharing her oocytes.
Discussion
The participation differed between countries. In the Czech Republic, all
centres performing oocyte donation participated. In others countries,
only a small portion of the IVF centres provided data. Still, the number
of centres does not necessarily indicate the coverage within a country
since not all IVF centres offer oocyte donation. A view on the reliability
can be better obtained by comparing the numbers with the EIM data.
The countries of the participating centres produced 94.9% of the esti-
mated number of donors aspiration reported by EIM in 2009. Among
those countries, the number of forms received for the study represents
9.9%of the aspirations for oocyte donation in 2009, ranging from2.4% in
Russia to 75.2% inGreecewith 7.2%Spain, 7.8%Belgium, 8.3%UK, 9.4%
France, 9.7%Czech Republic, 17.3%Ukraine, 36.9% Finland, 39.4%Por-
tugal, 43.7% Poland. This indicates a relatively good participation inmost
countries.
Relationship between donor and recipient
Although ‘anonymity’ usually refers to the relationship between donor
and offspring, the term can also be used for the relationship between
donor and recipient. Frequently, the terms ‘known’ and ‘unknown’
are used to refer to the relationship between donor and recipient
at the moment of the donation. Some countries have regulation or
legislation on this point, others have not. Poland, for instance, has
no regulation on this point. It is up to the centres to decide. The
overwhelming majority of their donations was anonymous but
donations within the family and donations to known donors were per-
formed in Poland (Kurzawa, personal communication). The percen-
tages for France were remarkable on this point because anonymity
is legally imposed and donors are not allowed to donate to a speciﬁc
person.
For Belgium, there is no conﬂict between the results and the legisla-
tion.Although theBelgian law imposes anonymity, it allows knowndona-
tion if both donor and recipient agree. From two studies on oocyte
donors in Belgium, we know that 15% of oocyte donors are
unknown to the recipient couples or women (Baetens et al., 2000; Lar-
uelle et al., 2011). This broadly correspondswith the data fromour study
in which 26% reported to donate to an unknown person.
Relationship between donor and donor
offspring
There is an obvious link between the results in this section and the legis-
lation in the country. Both the UK and Finland adopted a law that obliges
donors to be identiﬁable. It is therefore remarkable that in these coun-
tries a small percentage of donors still indicated that theywill be anonym-
ous. In the case of the UK, this amounted to 15.5%. There are several
possible explanations. One explanation would be that counselling did
not make this point clear to the donors. Another explanation would
be that they misunderstood the question and interpreted it as their
current position vis-a`-vis the child. The wording of the question makes
this interpretation difﬁcult (‘For the future child you will be anonymous
or identiﬁable?’ and ‘Identiﬁable means that your name may be released
to the child at a later age’) but it cannot be excluded. The reverse could
also be found in countrieswith legally imposed anonymity such as France
and the Czech Republic. In France, for instance, 6.7% answered ‘identi-
ﬁable’ while this was not allowed according to the law. In the Czech Re-
public, this was 4%. A possible explanation is that some centres did not
follow the law strictly and allowed sisters or good friends to donate dir-
ectly to each other.
Furthermore, there is no evident relationship between known/
unknown donors and anonymity/identiﬁability for the offspring.
A known donor (a donor whose identity is known to the recipient at
the moment of donation) is not necessarily known or identiﬁable to
the offspring. The two Belgian studies (Baetens et al., 2000; Laruelle
et al., 2011) showed that recipients who used a known donor frequently
decided neither to inform the child about the donor conception nor
about the identity of the donor.
Age of the donor
Many countries have aminimumage of 18 years foroocyte donation (age
ofmajority). Besides the basic legal reasons, this age limit is also based on
the wish to include only women with sufﬁcient psychological maturity.
The upper age limit is based on two considerations: women over 35
years have a lower response to the hormonal stimulation (fewer
oocytes are collected) and a higher aneuploidy rate. Therefore, most
centres have a 35-year age limit. However, this is not necessarily a
legal rule and centres may accept exceptions. In Belgium, for instance,
women older than 35 years are accepted when they donate to a speciﬁc
recipient who has been counselled about the implications of the donor’s
age. Also in the UK, the age limits may be interpreted ﬂexibly in cases of
directdonation.Othercountriesmayacceptolderdonors because there
is great scarcity and thus no alternative. The majority of the donors over
35 years could be found in Belgium and France.
Residence of the donor
Only in Belgium a considerable minority of donors was not living in the
country. This was also corroborated by the national data collected by
BELRAP (College of Physicians for Assisted Reproduction Therapy,
2011, 2012). In a report of the High Health Council, the data showed
that in 2008, 64.4% of the oocyte donors resided in Belgium, 27.7% in
another European country and 7.4% were unknown. It is unclear
whether the donors from outside Europe were included in the category
‘unknown’.When the residence of the donor oocyte recipient was con-
sidered, the data indicated that 50.5% of the recipients had residence in
Belgium, 42.4% in Europe and 5.8% unknown (High Health Council,
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2010). The present study conﬁrmed that most non-residents (17/18)
donated to foreign recipients. This was a typical case of cross-border re-
productive care performed for reasons of law evasion (Pennings et al.,
2009). There aremany reasonswhy people prefer to donate to a speciﬁc
other person (genetic link, familiaritywith and trust in the recipient, etc.).
People who attribute great importance to these aspects are willing to
travel in order to obtain these aspects.
Country of origin of the donor
Womenwho immigrate into a country are frequently situated in the lower
social classes. As such, the ﬁnancial compensation may be especially at-
tractive to them. In total, 13% of the women were not born in the
country inwhich theydonated. Immigration streamsare, however, difﬁcult
to present. UK for instance is a popular destination for many people.
Countries such as Greece that border poor countries will obviously also
attract many immigrants. It is impossible to say on the basis of our data
whether the number of donors coming from other countries was dispro-
portionate in comparison to the total presence of immigrants in the coun-
tries.
Number of donations
There is an ongoing debate about the possible negative effects of the
stimulation and oocyte retrieval on women. No evidence of harmful
effects has been provided. Most countries do not have a direct limit on
the number of times a donor can donate. Only Portugal has speciﬁc
rules: a donor cannot donate more than three times and the donations
must be .6 months apart. However, there is often indirect regulation
of the number of stimulation cycles through the maximum number of
donor offspring or the number of families that can receive a donor’s
gametes. In Belgium, this is ﬁxed at 6 women; in Greece, 10 children
but excluding siblings of already existing children; in Finland, a
maximum of 5 families; and 10 families in the UK. No regulation exists
in Poland, Russia and Ukraine on this point.
Without evidence of harmful effects, the question is why there seems
to exist a negative attitude about multiple donations. The assumption
seems to be that poor women are lured into this trap or may see this
as their only way to make money. However, although we found a rela-
tionship between multiple donations and ﬁnancial compensation, many
studies found that most donors (including altruistically motivated
donors) would donate again (Purewal and van den Akker, 2009). In
the right setting, the psychological beneﬁts outweigh the physical
burden. In general, in our study only 11% of all donors donated three
times or more.
Educational level
The educational level is difﬁcult to interpret because of the category of
‘technical/professional’; depending on the country, this is a low-level
education (slightly below secondary education) or a high education
(slightly lower than university degree). Our data however seem to indi-
cate that this category is situated in between secondary education and
university. More than half of the donors had a higher than secondary
level of education. The only exception here was the Czech Republic
with only 9% above secondary level.
Many people are convinced that the proportion of students may be
explained by the compensation. However, the high proportion of stu-
dents in countries like Portugal and Finland cannot be explained by the
compensation (of 625E and 250E, respectively). Other factors, such
as recruitment strategies, may have a larger impact.
Reproductive history
A little more than half of the donors had proven their fertility. This selec-
tion criterion increases the chance of having a suitable donor. The rule of
proven fertility may also be defended on the basis of improved informed
consent: women who already have a child understand better than non-
mothers what it means to help others to have a child and to have a gen-
etically related child that will be raised by another person. To a certain
extent, motherhood will correlate with age of the donor and civil
status. However, in some countries, motherhood is imposed by law. In
France, for instance, the law restricted oocyte donation to women
who have reproduced. A recent law has changed this and allows non-
mothers todonate (France, 2011).Donorswill also have theopportunity
to freezeﬁveoocytes for themselves for futureuse if theywant.Ukrainian
and Russian centres also demanded that donors are mothers.
In the literature, it has been noted that some donors were motivated
tomake up for a loss such as a past abortion (Klock et al., 2003). German
et al. (2001) found differences between a low compensation group
(2500$) and a high compensation group (5000$) in that the latter
group had higher numbers of previous pregnancies and a signiﬁcantly
higher number of previous abortions. We could not corroborate nor
falsify these ﬁndings in our study.
Reimbursement/compensation and motives
for donation
The amount of compensation is a highly contentious issue in the discus-
sion on the practice of oocyte donation since it is linkedwith the question
of exploitation of women and commodiﬁcation of the human body. The
data we collected are, however, difﬁcult to interpret. First, even when
there is a ﬁxed amount of compensation, there may be a huge variation
in amounts given within the country. Second, it is not always clear
whether the amount covers only reimbursement of expenses or
whether it also serves to compensate for discomfort, loss of time, etc.
Third, when a ﬁxed amount is paid, it is not always clear which elements
it is supposed to cover. Finally, the same amount of money may have a
completely different effect on women in one country compared with
the next. To cover these differences, we applied the PPP exchange
rates. If one fears that the amount that is offered would constitute a
form of pressure or coercion on women, it is likely that this will have
an effect mainly on poorer women.
Given the controversial status of oocyte donation, there is a risk that
higher standards are introduced than for other types of donation of body
material. Some people argue that this heightened standard is justiﬁed by
the fact that there are certain (be it small) risks involved for the physical
and psychological well-being of the donor. However, we will not enter
that debate here.Wewould like to focus on another aspect of the heigh-
tened standard, namely the purity of motives (Pennings, 2005). Most
people have more than one reason for most of their actions. There is
no reason to assume that this would be different for oocyte donation.
In fact, in many studies ‘commercial’ donors have also reported altruistic
motives (Purewal andvandenAkker,2009).Theproblem is that the label
‘commercial’mayrefer to twodifferentmeanings: (i) donorswho receive
payment for their donation and (ii) donorswho aremotivated bymoney.
Theoretically, there does not have to be a relationship between receiving
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money or compensation and the motives of people. The fact that a
person receives compensation or money does not mean that she is
merely motivated by that money. People ﬁnd it very difﬁcult to suppress
the conclusion that if a ﬁnancial beneﬁt or self-interest is present, that is
theonlymotive that counts.However, this rule is applied very selectively.
Most people do not conclude from the fact that a doctor is being paid for
his/her services that he/she is not motivated by the desire to help the
patient. Likewise, the fact that an oocyte donor is compensated for
her efforts does not mean that she is not motivated by the wish to
help the infertile. The presence of a quid pro quo does not exclude an al-
truistic motive (Pennings, 2005). If people are motivated by a desire to
help others, they may be easier to persuade to actually help when they
also stand to beneﬁt from it or when they have the perception that they
are at least not losing anything. Our data on the combination of motives
to donate, and especially the high number of donors who indicate both
altruism and ﬁnancial gain, seem to corroborate this conclusion.
Still, we wanted to ﬁnd out whether the amount that is offered as
payment or compensation correlates with motives for donation. Are
countries that offer the highest amount of money (in PPP terms) also
the countries with the highest percentage of purely ﬁnancially motivated
donors?Thiswasdifﬁcult tomeasure given the variationbetweencentres
within one country and between countries. Still, our study conﬁrms the
ﬁnding from Lindheim et al. (2001) that ﬁnancial motivation was greater
for donors who received a higher sum. In Belgium, for instance, some
clinics gave a ﬁxed sum of 500E while another gave 2000E. Among
those donors who answered the question, 94.1% were purely altruistic-
ally motivated in the 500E group compared with 52.9% on the 2000E
group. A similar trend was noticeable in Greece. However, the latter
ﬁnding could not be conﬁrmed for other countries because the differ-
ences in amount of compensation between the centreswere insufﬁcient.
Nevertheless, these relationships may also remind us of a possible effect
of social desirability in the answers by the donors This study demon-
strated that motivation varied with the amount of money paid to the
donor. Those indicating a ﬁnancial motivation were expecting a signiﬁ-
cantly higher amount of money (mean+ SD: 867E+ 253 than those
with both a ﬁnancial and altruistic motive (912E+305) and those
with purely altruistic motivation (706E+380); recalculated in purchas-
ing power, the amount was, respectively, 1357E+706; 1188E+594;
and 821E+ 542.
Egg sharing
Since the start, there has been a discussion on the acceptability of egg
sharing. Two ethical issues remain: ﬁrst, whether reimbursement of a
cycle can/should be considered as indirect payment and second,
whether theofferof a freeorpartially free cyclewould jeopardize the vol-
untarinessof thedonation. In this study,wehave treated ‘own treatment’
as a separate motive from the ﬁnancial motive because we believe that
these are different motives. Nevertheless, both ﬁnancially motivated
and treatment motivated donors enjoy a personal beneﬁt compared
with purely altruistically motivated donors. Inmost studies on themotiv-
ation of egg sharers, it was found that the willingness to help another
couple was also present in the majority of these donors. Most egg
sharers seemed to have mixed motives (Purewal and van den Akker,
2009; Gu¨rtin et al., 2012).
It would be logical that egg sharing would be especially popular in
countries with bad reimbursement systems. Regulations governing
publicly ﬁnanced IVF coveragewere again highly variable between coun-
tries (Berg Brigham et al., 2013). This makes it very difﬁcult to ﬁnd trends
in utilization and effects on donor numbers.Nevertheless, the two coun-
tries with many egg sharers conﬁrm the suggestion to a certain extent:
Poland does not reimburse IVF and the National Health System in the
UK most of the time only reimburses one cycle with wide inter-regional
variations. Still, while low reimbursement may promote egg sharing,
more factors are needed to explain this practice since many other coun-
tries do not provide public funding for ART either and still no egg sharing
occurs. Belgium has had a very generous reimbursement system since
2007, with six stimulation cycles fully reimbursed. Pennings and Devroey
(2006) have demonstrated that the introduction of this system has led
to a decrease in egg sharers, at 70%. The latest BELRAP report,
however, showed an increased egg sharing activity. A possible explanation
is that the current egg sharers are foreign patients who are not eligible for
funding by the Belgian social security. This was conﬁrmed in the latest
BELRAP report for 2009 and 2010 (College of Physicians for Assisted Re-
production Therapy, 2011, 2012). In 2009, 65 of 67 fresh sharing cycles
were performed by patients without social security. In 2010, it was
82 out of 85. It can be expected that the majority of these patients were
of foreign origin.
Conclusion
This was the ﬁrst report of oocyte donor characteristics in several Euro-
pean countries resulting from an international empirical study. The study
documented a considerable variation of donor characteristics and moti-
vations between European countries.
Oocyte donation raises many broad social, ethical and political pro-
blems which require a coordinated effort from various stakeholders,
such as patients organizations, professional societies and policy
makers, both at the national and European level. The safety aspect and
the condition of altruism are covered by the European Commission
Tissues and Cells directive. Nevertheless, it is obvious from our study
that the notion of proportional and fair compensation of oocytes
donors has a very wide margin of appreciation within the countries of
the European Union, where some donors received what might be con-
strued as a disproportionate amount of compensation when translated
into PPP.
A quite striking ﬁnding of this study was that, in countries without le-
gislation, there was as much variation between centres within the coun-
tries as between countries. Every element that was not strictly
determined by law is prone to variations. For instance, the minimal age
was 18 years according to most laws but some centres imposed a
higher minimum age on a voluntary basis. The same variation applied
to maximum age and conditions such as motherhood, etc. Although
such variation is frequently frowned upon, there seems to be no good
reason why such variations should be avoided or would be harmful.
It is very difﬁcult to determine on the basis of the present data why
some countries, such as Spain and the Czech Republic, have more
donors than others. Most likely, the explanation will differ from
country to country. The type of donor that is attracted will depend on
the rules of the donation practice, i.e. whether anonymity is guaranteed,
whether reimbursement/payment is provided, etc.However, one factor
cannot explain the situation across all countries.
One of the most contentious issues, i.e. compensation or payment,
proved to be highly complicated. A strict prohibition on any kind of
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compensation above the level of provenexpenses clearly had thedesired
effect of abolishing ﬁnancial motives. France demonstrated this beyond
doubt. However, France is also one of the countries with a low
number of oocyte donations. A system like Finland, where one added
250E on top of proven expenses, still maintained a high degree of altru-
istically motivated donors. Again, it seems perfectly defendable that
every country should be able to decide for itself which system should
apply on its territory. Still, a country thatwants to hold on to free and vol-
untary donations should look carefully at the results of this study. The
percentage of purely ﬁnancially motivated donors shows that some
countries may have reason to re-assess their system. The information
on the motivation of donors in different countries may also be very
useful for recipients who are concerned about this speciﬁc aspect.
On the basis of the current study, there is little reason to start an inter-
national oocyte donor registry. The number of donors with residence
outside the country where they donate is very small (1.6%). The pres-
ence of a small but not insigniﬁcant percentage of donors with a different
countryoforigin does raise someconcernsbecauseonemayassume that
this is proportionally an underprivileged and vulnerable group ofwomen.
Monitoring the oocyte donation activity at the national level is strongly
recommended because new developments, such as the establishment
of oocyte banks, may drastically alter the practice in a short time period.
Supplementary data
Supplementarydata areavailable athttp://humrep.oxfordjournals.org/.
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